| |
| |
|
| Insider
Information: |
Falberg Kathryn E |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
909,461 |
|
|
Indirect Shares
|
402,106 |
|
|
| Direct
Value |
$52,251,947 |
|
|
|
Indirect Value
|
$8,674,191 |
|
|
| Total
Shares |
1,311,567 |
|
|
| Total
Value |
$60,926,138 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 48.2%
|
 -81.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2016-05-04 |
358,253 |
2007-05-15 |
0 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
CFO and COO |
2009-06-16 |
0 |
|
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP and CFO |
2014-03-05 |
133,387 |
2012-08-16 |
0 |
Premium* |
|
|
Medivation Inc |
MDVN |
Director |
2016-09-28 |
0 |
2016-09-28 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2015-05-06 |
12,572 |
|
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2016-07-15 |
2,640 |
2016-07-15 |
0 |
Premium* |
|
|
Trade Desk, Inc. |
TTD |
Director |
2024-03-08 |
242,609 |
2024-03-08 |
50,000 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
Director |
2017-04-17 |
53,937 |
2017-04-17 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Director |
2023-06-15 |
46,900 |
2023-06-15 |
102,106 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director |
2021-06-10 |
59,163 |
2018-07-02 |
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2022-11-30 |
0 |
2022-12-05 |
250,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
112 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2008-05-08 |
4 |
A |
$4.94 |
$74,100 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| ABIO |
Nuvelo Inc |
CFO and COOOfficer |
• – – |
2009-02-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,000 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2009-05-07 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
50,000 |
0 |
- |
|
| ABIO |
Nuvelo Inc |
CFO and COO |
• – – |
2009-06-16 |
4 |
S |
$3.58 |
$75,851 |
D/D |
(21,000) |
0 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2010-05-06 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
70,000 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2010-08-30 |
4 |
B |
$8.53 |
$219,127 |
I/I |
25,689 |
25,689 |
1.99 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2010-08-31 |
4 |
B |
$8.93 |
$217,097 |
I/I |
24,311 |
50,000 |
1.99 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2010-11-30 |
4 |
A |
$6.43 |
$3,768 |
D/D |
586 |
586 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2011-05-05 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
90,000 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2011-05-31 |
4 |
A |
$6.43 |
$3,080 |
D/D |
479 |
1,065 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2011-11-11 |
4 |
B |
$37.36 |
$112,080 |
I/I |
3,000 |
53,000 |
1.99 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2011-11-30 |
4 |
A |
$6.43 |
$15,194 |
D/D |
2,363 |
3,428 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-11 |
4 |
D |
$48.60 |
$4,230,970 |
D/D |
(87,057) |
58,201 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-11 |
4 |
OE |
$7.35 |
$2,079,163 |
D/D |
141,830 |
87,282 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,201) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(53,000) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
58,201 |
58,201 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2012-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
53,000 |
53,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
110,000 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – • |
2012-05-31 |
4 |
A |
$6.43 |
$16,596 |
D/D |
2,581 |
60,782 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
95,782 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2012-08-16 |
4 |
S |
$47.48 |
$332,360 |
D/D |
(7,000) |
88,782 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2012-08-16 |
4 |
S |
$47.57 |
$2,521,210 |
I/I |
(53,000) |
0 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-11-13 |
4 |
B |
$5.21 |
$260,500 |
D/D |
50,000 |
160,000 |
2.39 |
- |
|
112 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
